144TiP - CheckMate 227: A randomized, open-label phase 3 trial of nivolumab, nivolumab plus ipilimumab, or nivolumab plus chemotherapy versus chemotherapy in chemotherapy-naïve patients with advanced non-small cell lung cancer (NSCLC)
- Resource Type
- Abstract
- Source
- In
Annals of Oncology April 2017 28 Supplement 2:ii50-ii51 - Subject
- Language
- ISSN
- 0923-7534